XML 16 R5.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Consolidated Statements of Changes in Stockholders’ Equity (Unaudited) - USD ($)
Total
Preferred Stock
Common Stock
Class A Common Stock
Common Stock
Class C Common Stock
Additional Paid-In Capital
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023   0 24,410,075 3,213,678    
Beginning balance at Dec. 31, 2023 $ 10,434,042 $ 0 $ 2,441 $ 321 $ 72,644,419 $ (62,213,139)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock for Credova Merger (in shares)     2,920,993      
Issuance of common stock for Credova Merger 14,137,606   $ 292   14,137,314  
Issuance of shares for consulting arrangement (in shares)     183,349      
Issuance of shares for consulting arrangement 887,409   $ 18   887,391  
Issuance of shares for fully vested restricted stock units (in shares)     663,500      
Issuance of shares for fully vested restricted stock units 0   $ 66   (66)  
Share-based compensation 5,410,894       5,410,894  
Net loss (12,576,831)         (12,576,831)
Ending balance (in shares) at Mar. 31, 2024   0 28,177,917 3,213,678    
Ending balance at Mar. 31, 2024 18,293,120 $ 0 $ 2,817 $ 321 93,079,952 (74,789,970)
Beginning balance (in shares) at Dec. 31, 2023   0 24,410,075 3,213,678    
Beginning balance at Dec. 31, 2023 10,434,042 $ 0 $ 2,441 $ 321 72,644,419 (62,213,139)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (23,812,077)          
Ending balance (in shares) at Jun. 30, 2024   0 28,177,917 3,213,678    
Ending balance at Jun. 30, 2024 12,229,635 $ 0 $ 2,817 $ 321 98,251,713 (86,025,216)
Beginning balance (in shares) at Dec. 31, 2023   0 24,410,075 3,213,678    
Beginning balance at Dec. 31, 2023 10,434,042 $ 0 $ 2,441 $ 321 72,644,419 (62,213,139)
Ending balance (in shares) at Dec. 31, 2024   0 39,575,499 3,213,678    
Ending balance at Dec. 31, 2024 26,850,206 $ 0 $ 3,958 $ 321 146,746,355 (119,900,428)
Beginning balance (in shares) at Mar. 31, 2024   0 28,177,917 3,213,678    
Beginning balance at Mar. 31, 2024 18,293,120 $ 0 $ 2,817 $ 321 93,079,952 (74,789,970)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Share-based compensation 5,171,761       5,171,761  
Net loss (11,235,246)         (11,235,246)
Ending balance (in shares) at Jun. 30, 2024   0 28,177,917 3,213,678    
Ending balance at Jun. 30, 2024 12,229,635 $ 0 $ 2,817 $ 321 98,251,713 (86,025,216)
Beginning balance (in shares) at Dec. 31, 2024   0 39,575,499 3,213,678    
Beginning balance at Dec. 31, 2024 26,850,206 $ 0 $ 3,958 $ 321 146,746,355 (119,900,428)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock from Employee Stock Purchase Plan (in shares)     3,995      
Issuance of shares for fully vested restricted stock units (in shares)     379,518      
Issuance of shares for fully vested restricted stock units 0   $ 38   (38)  
Share-based compensation 3,622,845       3,622,845  
Net loss (4,447,345)         (4,447,345)
Ending balance (in shares) at Mar. 31, 2025   0 39,959,012 3,213,678    
Ending balance at Mar. 31, 2025 26,025,706 $ 0 $ 3,996 $ 321 150,369,162 (124,347,773)
Beginning balance (in shares) at Dec. 31, 2024   0 39,575,499 3,213,678    
Beginning balance at Dec. 31, 2024 26,850,206 $ 0 $ 3,958 $ 321 146,746,355 (119,900,428)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (12,813,325)          
Ending balance (in shares) at Jun. 30, 2025   0 42,676,029 3,213,678    
Ending balance at Jun. 30, 2025 22,451,393 $ 0 $ 4,267 $ 321 155,160,558 (132,713,753)
Beginning balance (in shares) at Mar. 31, 2025   0 39,959,012 3,213,678    
Beginning balance at Mar. 31, 2025 26,025,706 $ 0 $ 3,996 $ 321 150,369,162 (124,347,773)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock for asset acquisition (in shares)     2,000,000      
Issuance of common stock for asset acquisition 4,500,000   $ 200   4,499,800  
Issuance of common stock for at-the-market offering, net (in shares)     164,971      
Issuance of common stock for at-the-market offering, net 361,528   $ 16   361,512  
Issuance of shares for fully vested restricted stock units (in shares)     552,046      
Issuance of shares for fully vested restricted stock units 0   $ 55   (55)  
Share-based compensation (69,861)       (69,861)  
Net loss (8,365,980)         (8,365,980)
Ending balance (in shares) at Jun. 30, 2025   0 42,676,029 3,213,678    
Ending balance at Jun. 30, 2025 $ 22,451,393 $ 0 $ 4,267 $ 321 $ 155,160,558 $ (132,713,753)